AHA today Oct. 24 a Special Bulletin with updates from Baxter on its efforts to increase access to and supply of IV solutions in response to the effects of Hurricane Helene on its manufacturing facility in North Carolina. Baxter anticipates restarting the highest-throughput IV solutions manufacturing line at the impacted plant within the next week. In addition, the Food and Drug Administration authorized temporary importation for a variety of products from two additional Baxter plants in Thailand and Singapore, bringing the total number of facilities authorized to import products to seven. See AHA’s Special Bulletin for more updates.

Related News Articles

Headline
A JAMA study published Aug. 20 found that nearly 63% of all U.S. drug production facilities from 2019 through 2024 were in counties where a weather disaster…
Headline
B. Braun Medical has voluntarily recalled two lots of Lactated Ringer’s Injection USP 1000 mL and 0.9% Sodium Chloride Injection USP 1000 mL IV fluids due to…
Headline
The White House Aug. 13 released an executive order directing the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness…
Headline
The Food and Drug Administration has identified a Class I recall of Draeger SafeStar and TwinStar Filters due to a risk of misleading carbon dioxide readings.…
Headline
The Food and Drug Administration Aug. 8 announced an end to the national shortage of sodium chloride 0.9% IV solutions products. The agency said it continues…
Headline
The Food and Drug Administration Aug. 7 announced a new program to help improve the domestic pharmaceutical supply chain by increasing regulatory…